Abstract
This Viewpoint discusses the benefits of expanded access research, the usefulness of expanded access data, the issues surrounding cost and transparency, and the adjusted role of institutional review boards.
Original language | English |
---|---|
Pages (from-to) | 1057-1058 |
Number of pages | 2 |
Journal | JAMA |
Volume | 329 |
Issue number | 13 |
DOIs | |
Publication status | Published - 4 Apr 2023 |